ArticleInflammatory bowel diseases2019

Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis.

Robert Battat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.